Francisco Cardoso

Research interests

Publications

• Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

  Brain · 2024 · 10.1093/brain/awae188

• Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

  Movement Disorders · 2023 · https://doi.org/10.1002/mds.29410

• Isolated Cervical Dystonia: Diagnosis and Classification

  Movement Disorders · 2023 · 10.1002/mds.29387

• Essential tremor

  Nature Reviews Disease Primers · 2021 · 10.1038/s41572-021-00314-w

• Neurological complications in patients with SARS-CoV-2 infection: a systematic review

  Arquivos de Neuro-Psiquiatria · 2020 · 10.1590/0004-282x20200051

• Coronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case

  Movement Disorders · 2020 · 10.1002/mds.28277

• Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories

  Movement Disorders Clinical Practice · 2019 · 10.1002/mdc3.12808

• Treatable inherited rare movement disorders

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.27140

• Data Analytics from Enroll‐ HD , a Global Clinical Research Platform for Huntington's Disease

  Movement Disorders Clinical Practice · 2016 · 10.1002/mdc3.12388

• Myorhythmia: Phenomenology, etiology, and treatment

  Movement Disorders · 2014 · 10.1002/mds.26093

• Sydenham's chorea

  Handbook of clinical neurology · 2011 · 10.1016/b978-0-444-52014-2.00014-8

• Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease

  Arquivos de Neuro-Psiquiatria · 2010 · 10.1590/s0004-282x2010000400005

• Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease

  Journal of Neurology · 2009 · 10.1007/s00415-009-5357-2

• Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

  Neuroscience Letters · 2009 · 10.1016/j.neulet.2009.10.062

• Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease

  Journal of Neuroimmunology · 2009 · 10.1016/j.jneuroim.2009.08.001

• DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA

  The Lancet Neurology · 2008 · 10.1016/s1474-4422(08)70022-x

• Seminar on choreas

  The Lancet Neurology · 2006 · 10.1016/s1474-4422(06)70494-x

• Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson's disease

  Movement Disorders · 2006 · 10.1002/mds.20763

• Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study)

  Movement Disorders · 2006 · https://doi.org/10.1002/mds.20806

• Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations

  European Journal of Neurology · 2006 · 10.1111/j.1468-1331.2006.01441.x

• Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea

  Neurology · 2005 · 10.1212/01.wnl.0000161840.62090.0e

• Anti–basal ganglia antibodies in acute and persistent Sydenham’s chorea

  Neurology · 2002 · 10.1212/wnl.59.2.227

• Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto‐reactive antibasal ganglia antibodies

  Annals of Neurology · 2001 · 10.1002/ana.1250

• Persistent Sydenham's chorea

  Movement Disorders · 1999 · 10.1002/1531-8257(199909)14:5<805::aid-mds1013>3.0.co;2-p

• Outcome after Stereotactic Thalamotomy for Dystonia and Hemiballismus

  Neurosurgery · 1995 · 10.1227/00006123-199503000-00009

• Cocaine‐related movement disorders

  Movement Disorders · 1993 · 10.1002/mds.870080210

Current projects

No projects listed.